Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

4 clinical studies listed.

Filters:

Severe Renal Impairment

Tundra lists 4 Severe Renal Impairment clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07946068

Aleniglipron Renal Impairment Study

The purpose of this study is to evaluate the effect of severe RI on IHD on the PK of aleniglipron to establish scientifically guided dosing recommendations in these special patient populations.

Gender: All

Ages: 18 Years - 85 Years

Updated: 2026-11-18

1 state

Renal Impairment
Severe Renal Impairment
COMPLETED

NCT04119843

Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function

The overall objective of this study is to evaluate the safety and diagnostic efficacy of Mangoral in liver MRI in participants with known or suspected focal liver lesions and severe renal impairment. The diagnostic efficacy of Mangoral will be assessed in terms of visualization of detected focal liver lesions in combined MRI (CMRI: combined Mangoral-enhanced and unenhanced MRI) compared to unenhanced MRI.

Gender: All

Ages: 18 Years - Any

Updated: 2026-11-10

18 states

Known or Suspected Focal Liver Lesions
Severe Renal Impairment
COMPLETED

NCT07840313

Prophylactic Desmopressin Before Native Kidney Biopsy in Severe Renal Impairment

This study evaluated whether giving desmopressin before a native kidney biopsy reduces bleeding complications in adults with severe renal impairment (eGFR \<30 mL/min/1.73 m²). Patients undergoing kidney biopsy were enrolled sequentially into two groups: a non-desmopressin group and a desmopressin group. Patients were monitored for 24 hours after biopsy for bleeding complications, including perinephric hematoma, a decrease in hemoglobin, blood in the urine, need for blood transfusion, and other complications. The study also evaluated whether desmopressin was associated with adverse effects such as low blood sodium levels.

Gender: All

Ages: 18 Years - 90 Years

Updated: 2026-09-25

1 state

Severe Renal Impairment
RECRUITING

NCT07734610

A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)

The purpose of this study is to learn what happens to nemtabrutinib in a person's body when given to participants with severe kidney disease and to healthy participants.

Gender: All

Ages: 18 Years - 80 Years

Updated: 2026-09-23

1 state

Severe Renal Impairment
Healthy